抗心型脂肪酸結合蛋白(H-FABP)多克隆抗體
Anti-Heart-type Fatty Acid Binding Protein (H-FABP) Polyclonal Antibody
MDGI; FABP11; H-FABP; O-FABP; Hfabp; FABP3; Fatty Acid Binding Protein 3, Muscle And Heart; Mammary Derived Growth Inhibitor; Fatty Acid Binding Protein 11; Muscle fatty acid-binding protein; Heart-ty
- 編號FAB243Po01
- 物種Sus scrofa; Porcine (Pig，豬)相同的名稱，不同的物種。
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種Homo sapiens (Human，人)
- 應用FCM
- 下載英文說明書 中文說明書
- 規(guī)格25test50test100test200test500test
- 價格暫無報價暫無報價暫無報價暫無報價暫無報價
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
產品包裝(模擬)
產品包裝(模擬)
Human CaCo-2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20μg/ml rabbit Anti-porcine H-FABP Polyclonal Antibody (Catalog FAB243Po01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1μg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
通過ISO 9001、ISO 13485質量體系認證
用法
Flow cytometry: 20μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務
相關產品
| 編號 | 適用物種：Sus scrofa; Porcine (Pig，豬) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB243Po01 | 心型脂肪酸結合蛋白(H-FABP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB243Po01 | 心型脂肪酸結合蛋白(H-FABP)多克隆抗體 | WB; IHC |
| FAB243Po01 | 抗心型脂肪酸結合蛋白(H-FABP)多克隆抗體 | FCM |
| MAB243Po21 | 心型脂肪酸結合蛋白(H-FABP)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB243Po | 心型脂肪酸結合蛋白(H-FABP)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB243Po | 心型脂肪酸結合蛋白(H-FABP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Molecular Medicine Reports | Protective effects of N (2)?L?alanyl?L?glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion[Pubmed:29393473] |
| Oncology?Letters | Hydrogen?rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus?activated kinase 2/signal transducer and activator of?…[Pubmed:29928398] |
| FASEB?Journal | Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure[Pubmed: 30230922] |